Klaus Tjelle Kristiansen

Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia – a post hoc evaluation of the COVID STEROID 2 trial

Tirupakuzhi Vijayaraghavan, B. K., Granholm, A., Munch, M. W., Kjær, M. B. N., Møller, M. H., Perner, A., Myatra, S. N., Jha, V., Jha, V., Jha, V., Hammond, N., Micallef, S., Venkatesh, B., Hammond, N., Lange, T., Munch, M. W., Myatra, S. N., Tirupakuzhi Vijayaraghavan, B. K., Saseedharan, S., Benfield, T. & 31 others, Wahlin, R. R., Rasmussen, B. S., Andreasen, Anne Sofie, Poulsen, L. M., Cioccari, L., Khan, M. S., Kapadia, F., Divatia, J. V., Brøchner, A. C., Bestle, Morten Heiberg, Helleberg, Marie, Michelsen, J., Padmanaban, A., Bose, N., Møller, A., Borawake, K., Kristiansen, Klaus Tjelle, Shukla, U., Chew, M. S., Ulrik, Charlotte Suppli, Kjær, M. B. N., Møller, Morten Hylander, Meyhoff, T. S., Vesterlund, G. K., Gluud, C., Lange, Theis, Marcussen, Klaus Vennick, Nielsen, H., Jensen, T. S., Perner, Anders & the COVID-STEROID 2 collaborators, T. C. 2. C., 2024, In: The Lancet Regional Health - Southeast Asia. 20, 8 p., 100293.

Research output: Contribution to journal › Journal article › Research › peer-review